help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HISADA, T.
Right arrow Articles by CHUNG, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HISADA, T.
Right arrow Articles by CHUNG, K. F.

Am. J. Respir. Crit. Care Med., Volume 160, Number 2, August 1999, 571-575

Cysteinyl-leukotrienes Partly Mediate Eotaxin-induced Bronchial Hyperresponsiveness and Eosinophilia in IL-5 Transgenic Mice

TAKESHI HISADA, MICHAEL SALMON, YASUYUKI NASUHARA, and K. FAN CHUNG

Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom

Eotaxin, a selective chemoattractant for eosinophils, induces lung eosinophilia and bronchial hyperresponsiveness (BHR) when administered intratracheally to interleukin-5 (IL-5) transgenic mice. We determined whether these effects of eotaxin were mediated through the production of cysteinyl-leukotrienes. IL-5 transgenic mice were administered eotaxin (5 µg) intratracheally after pretreatment with either diluent or a selective 5-lipoxygenase inhibitor SB210661 or a cysteinyl-leukotriene receptor antagonist, pranlukast. Twenty-four hours later, bronchial responsiveness to acetylcholine was measured and the degree of eosinophil influx was determined in bronchoalveolar lavage fluid (BALF) or in lung tissue. Both pranlukast and SB210661 significantly attenuated BHR induced by eotaxin with logPC50, which is the concentration of acetylcholine needed to increase baseline insufflation pressure by 50%, from -0.43 ± 0.16 to 0.39 ± 0.10 and from -0.22 ± 0.10 to 0.53 ± 0.10, respectively (p < 0.05). There was also a significant attenuation of the eosinophil counts in BALF and in airways. BALF levels of leukotriene C4 (LTC4) showed a significant increase after eotaxin from 23.9 ± 6.7 to 165.0 ± 35.0 pg/ml (p < 0.05) but were partially suppressed by both SB210661 (71.2 ± 21.0) and pranlukast (62.7 ± 11.5). Concentrations of LTB4 were not significantly changed. We conclude that eotaxin-induced effects in the airways of IL-5 transgenic mice are partly mediated by the activation of 5-lipoxygenase enzyme leading to the generation of cysteinyl-leukotrienes.




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
Y. Koike, T. Hisada, M. Utsugi, T. Ishizuka, Y. Shimizu, A. Ono, Y. Murata, J. Hamuro, M. Mori, and K. Dobashi
Glutathione Redox Regulates Airway Hyperresponsiveness and Airway Inflammation in Mice
Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S.-Y. Eum, K. Maghni, Q. Hamid, H. Campbell, D. H. Eidelman, and J. G. Martin
Involvement of the Cysteinyl-Leukotrienes in Allergen-Induced Airway Eosinophilia and Hyperresponsiveness in the Mouse
Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 25 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. K. Kumar and P. S. Foster
Modeling Allergic Asthma in Mice: Pitfalls and Opportunities
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 267 - 272.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. Berkman, S. Ohnona, F. K. Chung, and R. Breuer
Eotaxin-3 but Not Eotaxin Gene Expression Is Upregulated in Asthmatics 24 Hours after Allergen Challenge
Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 682 - 687.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. S. Salvi, M. T. Krishna, A. P. Sampson, and S. T. Holgate
The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma
Chest, May 1, 2001; 119(5): 1533 - 1546.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. J. FIGUEROA, R. M. BREYER, S. K. DEFOE, S. KARGMAN, B. L. DAUGHERTY, K. WALDBURGER, Q. LIU, M. CLEMENTS, Z. ZENG, G. P. O'NEILL, et al.
Expression of the Cysteinyl Leukotriene 1 Receptor in Normal Human Lung and Peripheral Blood Leukocytes
Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 226 - 233.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. STOKES PEEBLES Jr., R. DWORSKI, R. D. COLLINS, K. JARZECKA, D. B. MITCHELL, B. S. GRAHAM, and J. R. SHELLER
Cyclooxygenase Inhibition Increases Interleukin 5 and Interleukin 13 Production and Airway Hyperresponsiveness in Allergic Mice
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 676 - 681.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Hojo, M. Suzuki, K. Maghni, Q. Hamid, W. S. Powell, and J. G. Martin
Role of Cysteinyl Leukotrienes in CD4+ T Cell-Driven Late Allergic Airway Responses
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 410 - 416.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society